Patient Note — 152994

progress_notes_152994_1_deid.txt

← Back to all patients Run PA Decision for this patient →

Demographics & Encounter

Patient ID152994 (PHI redacted)
Age / Gender76 / Female
Date of Service2026-04-06
Provider[PROVIDER_NAME]
FacilityPOTOMAC UROLOGY CENTER - Alexandria
PayerHighmark Medicare
Reason1. Kidney Stone

Diagnoses

N20.0 Nephrolithiasis
R39.15 Urgency of urination

Medications

Vitamin B-12 Vitamin D3 Donepezil HCl Atorvastatin Calcium Memantine HCl Trospium Chloride Celecoxib Estrace(Estradiol) 0.1 MG/GM Cream NO applicator, pea-sized amount at the tip of the finger Vaginal every other day hydroCHLOROthiazide Vitamin B12 Progress Note: [PROVIDER_NAME], MD 04/06/2026 Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com) Generated for Printing/Faxing/eTransmitting on: 04/18/2026 12:51 PM EDT 2/5 4/18/26, 9:51 AM Print Preview [PATIENT_NAME] DOB: [DOB] (76 yo F) Acc No. [ACCOUNT_ID] DOS: 04/06/2026 predniSONE DAYS Ditropan XL Famotidine Breo Ellipta Medication List reviewed and reconciled with the patient

Past Medical History

  • High Cholesterol
  • CNT
  • Bladder cancer

Vitals

RR 16.0
HR 81.0
BP 93/70
BMI 20.12
WEIGHT 110 lbs
HEIGHT_IN 62.0

Clinical Summary (HPI)

Kidney Stone: 76 year old female, with a history of ureteral stone and uterosepsis, presents for reassessment. Dr. Desai placed a left sided stent on 03/30/2026. She notes frequent urination and blood in her urine since stent placement. Bladder Cancer: Also, with history intermediate risk bladder cancer (s/p TURBT Aug 2023). +++++++++++ Cysto: Stable calcification at the dome of the bladder, consistent with previous biopsy sites (biopsied twice), with no evidence of malignancy. [11/19/2025] Cytology: Negative (Nov 2024) Bladder Bx: (1) Inflammation and calcifications (Feb 2024) Bladder biopsy: Scant papillary fragments of urothelium compatible with papillary urothelial neoplasm of low malignant potential. Calcified acellular debris. Muscularis propria is not identified (Aug 2023) Cysto (4/2023): Necrosis at prior resection sites, no tumor. Induction Mito (1-3/2023) TURBT (12/2022): LG Ta multifocal. (1) Left lateral bladder wall tumor, excision: Low grade papillary urothelial carcinoma. No invasion identified. No muscularis propria identified. (2) Left lateral bladder wall tumor, deep: muscularis propria. [03/14/2022] low grade papillary urothelial neoplasm, non invasive. no musularis propria (1/4/23) Given proximity to left UO RBUS performed and unremarkable. No hydronephrosis [3/2022] Initial Diagnosis 3/2022: LGTa. Initial Diagnosis Initial Diagnosis Yes Presenting complaint: Gross hematuria Staging Imaging: No Date of Index TURBT 03-2022 Index TURBT Pathology: LGTa AUA Ri

Raw Note (de-identified preview)

4/18/26, 9:51 AM Print Preview [PATIENT_NAME] DOB: [DOB] (76 yo F) Acc No. [ACCOUNT_ID] DOS: 04/06/2026 [PATIENT_NAME] 76 Y old Female, DOB: [DOB] Account: [ACCOUNT_ID]: [PHONE] [ADDRESS]- 1862 Home: [PHONE] Guarantor: [GUARANTOR_NAME] Insurance: Highmark Medicare PCP: [PROVIDER_NAME] Referring: [PROVIDER_NAME] Appointment Facility: POTOMAC UROLOGY CENTER - Alexandria Structured Data: How did you hear about us? : Primary Care Physician; Patient's temperature : 96.7; : 11/18/2022 04/06/2026 Progress Notes: [PROVIDER_NAME], MD Reason for Appointment 1. Kidney Stone History of Present Illness Kidney Stone: 76 year old female, with a history of ureteral stone and uterosepsis, presents for reassessment. Dr. Desai placed a left sided stent on 03/30/2026. She notes frequent urination and blood in her urine since stent placement. Bladder Cancer: Also, with history intermediate risk bladder cancer (s/p TURBT Aug 2023). +++++++++++ Cysto: Stable calcification at the dome of the bladder, consistent with previous biopsy sites (biopsied twice), with no evidence of malignancy. [11/19/2025] Cytology: Negative (Nov 2024) Bladder Bx: (1) Inflammation and calcifications (Feb 2024) Bladder biopsy: Scant papillary fragments of urothelium compatible with papillary urothelial neoplasm of low malignant potential. Calcified acellular debris. Muscularis propria is not identified (Aug 2023) Cysto (4/2023): Necrosis at prior resection sites, no tumor. Induction Mito (1-3/2023) TURBT (12/2022): LG Ta multifocal. (1) Left lateral bladder wall tumor, excision: Low grade papillary urothelial carcinoma. No invasion identified. No muscularis propria identified. (2) Left lateral bladder wall tumor, deep: muscularis propria. [03/14/2022] low grade papillary urothelial neoplasm, non invasive. no musularis propria (1/4/23) Given proximity to left UO RBUS performed and unremarkable. No hydronephrosis [3/2022] Initial Diagnosis 3/2022: LGTa. Initial Diagnosis Initial Diagnosis Yes Presenting complaint: Gross hematuria Staging Imaging: No Date of Index TURBT 03-2022 Index TURBT Pathology: LGTa AUA Risk Stratification AUA NMIBC Low Risk NMIBC Low Risk Features LG Solitary Ta less than 3cm Initial Intravesical therapy No Recurrence Initial (First) Recurrence Yes Date of TURBT/biopsy 12-2022 TURBT Pathology LGTa Progress Note: [PROVIDER_NAME], MD 04/06/2026 Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com) Generated for Printing/Faxing/eTransmitting on: 04/18/2026 12:51 PM EDT 1/5 4/18/26, 9:51 AM Print Preview [PATIENT_NAME] DOB: [DOB] (76 yo F) Acc No. [ACCOUNT_ID] DOS: 04/06/2026 AUA Risk Stratification (based on recurrence) AUA NMIBC intermediate risk Yes Risk Stratification AUA Risk Stratification intermediate risk Intermediate Risk features Recurrence within 1 year, LG Ta,LG Ta, multifocal Last TURBT Information Last TURBT Date 12/15/2022 Tumor Size < 3 cm Tumor Grade low grade Clinical Stage Ta Muscle in specimen? No Tumor site multifocal tumor Variant hist